Q32 Bio (QTTB) Share-based Compensation (2017 - 2026)

Q32 Bio's Share-based Compensation history runs 10 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 15.35% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $5.5 million (up 2.82% YoY), while the FY2025 annual figure was $5.3 million, up 19.81% from the prior year.
• Share-based Compensation was $1.5 million for Q1 2026 at Q32 Bio, up from $1.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q1 2022 to a low of $296000.0 in Q1 2023.
• Historically, Share-based Compensation has averaged $1.5 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation tumbled 92.69% in 2023, then surged 359.14% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $3.1 million in 2022, then slumped by 83.13% to $521000.0 in 2023, then jumped by 140.12% to $1.3 million in 2024, then advanced by 17.43% to $1.5 million in 2025, then advanced by 5.38% to $1.5 million in 2026.
• The last three Share-based Compensation figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.